PHASE II STUDY OF ALL-TRANS RETINOIC ACID ADMINISTERED INTERMITTENTLY FOR HORMONE REFRACTORY PROSTATE CANCER

The Journal of Urology ◽

10.1016/s0022-5347(01)62090-1 ◽

1999 ◽

Vol 161 (1) ◽

pp. 173-175 ◽

Author(s):

S. CULINE ◽

A. KRAMAR ◽

J.P. DROZ ◽

C. THEODORE

Keyword(s):

Prostate Cancer ◽

Retinoic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Hormone Refractory

Download Full-text

PHASE II STUDY OF ALL-TRANS RETINOIC ACID ADMINISTERED INTERMITTENTLY FOR HORMONE REFRACTORY PROSTATE CANCER

The Journal of Urology ◽

10.1097/00005392-199901000-00049 ◽

1999 ◽

pp. 173-175 ◽

Author(s):

S. CULINE ◽

A. KRAMAR ◽

J. P. DROZ ◽

C. THEODORE

Keyword(s):

Prostate Cancer ◽

Retinoic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Hormone Refractory

Download Full-text

A phase II trial of all- trans -retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050582 ◽

1997 ◽

Vol 39 (4) ◽

pp. 349-356 ◽

Author(s):

D. L. Trump ◽

David C. Smith ◽

Dwight Stiff ◽

Adedayo Adedoyin ◽

Roger Day ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Retinoic Acid ◽

Phase Ii ◽

Phase Ii Trial ◽

Pharmacokinetic Analysis ◽

Hormone Refractory Prostate Cancer ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Hormone Refractory

Download Full-text

Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

Molecular Biology Reports ◽

10.1007/s11033-010-0102-6 ◽

2010 ◽

Vol 38 (1) ◽

pp. 249-259 ◽

Author(s):

Bulent Karabulut ◽

Burcak Karaca ◽

Harika Atmaca ◽

Asli Kisim ◽

Selim Uzunoglu ◽

...

Keyword(s):

Prostate Cancer ◽

Retinoic Acid ◽

Zoledronic Acid ◽

Prostate Cancer Cell ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cell Lines ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Hormone Refractory

Download Full-text

A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81827-9 ◽

1999 ◽

Vol 35 ◽

pp. S349 ◽

Author(s):

A. Einstein ◽

R. Lush ◽

R. Rago ◽

G. Bubley ◽

W.D. Henner ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

Hormone Refractory ◽

First Line Treatment

Download Full-text

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽

10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x ◽

1993 ◽

Vol 72 (6) ◽

pp. 1965-1968 ◽

Author(s):

Timothy M. Kuzel ◽

Martin S. Tallman ◽

Daniel Shevrin ◽

Edward Braud ◽

Lary Kilton ◽

...

Keyword(s):

Prostate Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Center ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Download Full-text

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Investigational New Drugs ◽

10.1023/b:drug.0000047109.76766.84 ◽

2005 ◽

Vol 23 (1) ◽

pp. 79-84 ◽

Author(s):

Tahir Latif ◽

Laura Wood ◽

Cindy Connell ◽

David C. Smith ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II Study of Vinorelbine and Low-Dose Docetaxel in Chemotherapy-Naive Patients with Hormone-Refractory Prostate Cancer

The Cancer Journal ◽

10.1097/00130404-200307000-00011 ◽

2003 ◽

Vol 9 (4) ◽

pp. 286-292 ◽

Author(s):

Alan J. Koletsky ◽

Manuel L. Guerra ◽

Lori Kronish

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II study of vlnorelbine in patients with hormone refractory prostate cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)84523-6 ◽

1997 ◽

Vol 33 ◽

pp. S33

Author(s):

A. Caty ◽

S. Oudard ◽

Y. Humblet ◽

M. Beauduin ◽

E. Suc ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

899 PUBLICATION A phase II study of sequential chemotherapy with docetaxel-estramustine phosphate (DE) followed by mitoxantrone-prednisone (MP) in patients (pts.) with metastatic hormone refractory prostate cancer (MHRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81194-2 ◽

2005 ◽

Vol 3 (2) ◽

pp. 258

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Estramustine Phosphate ◽

Sequential Chemotherapy ◽

Hormone Refractory

Download Full-text